Globus Medical Launches ELSA Expandable Lateral Spacer System

Globus Medical Inc., a musculoskeletal solutions company, announced the launch of two innovative lateral expandable interbody spacers with integrated screw fixation, ELSA AL and ELSA-ATP, the latest additions to Globus’ unmatched expandable solutions. These next generation expandable implants provide an optimized fit for the patient, allowing for restoration of sagittal balance and enhanced structural fixation.
 
Globus Medical is the market leader in expandable interbody spacers with over 20 expandable implant solutions supported by 15 years of clinical experience. Globus Medical’s full line of expandable products has enabled surgeons to treat over 130,000 levels.
 
“ELSA AL is the alternative to RISE-L for selected cases in which maximizing segmental lordosis is indicated,” said Dr. Paul K. Kim, neurosurgeon at Carolina Neurosurgery & Spine Associates. “In conjunction with the ALL (anterior longitudinal ligament) release technique, ELSA AL has the potential to provide the most amount of segmental lordosis of any device on the market.”
 
Adjustable Lordosis Technology with ELSA AL
ELSA AL’s in situ adjustability and integrated screw fixation are designed to help correct sagittal balance and improve stability. The implant features exclusive adjustable lordotic technology that allows up to 30° of lordosis while maintaining a minimally invasive surgical corridor. With less disruption compared to traditional static spacers, ELSA AL provides maximum correction and additional fixation for increased segmental stability.
 
First Expandable Spacer for a Customized ATP Approach
ELSA-ATP is the only expandable spacer designed to avoid nerve complications associated with the direct lateral technique by using an anterior-to-psoas approach.
 
The Lateral Lumbar Interbody Fusion (LLIF) technique approaches the spine from the side of the patient, which allows for placement of a larger implant footprint and less disruption of the lower back muscles. The anterior-to-psoas approach is a modified LLIF procedure that avoids the psoas, a large muscle responsible for movement and flexion of the leg. Avoiding this muscle and its integrated nerves may help reduce post-operative complications such as thigh pain.
 
ELSA-ATP features angled integrated screws for direct fixation to the adjacent vertebrae. The spacer can be inserted at a minimal height and expanded in situ to minimize tissue disruption and maximize indirect decompression. A full suite of anterolateral access and insertion instruments makes ELSA-ATP the most comprehensive system on the market.
 
“Our product development team’s continued commitment to innovation has enabled us to design expandable interbody technology for nearly every surgical approach. The addition of these two unique ELSA spacers to our expandable lateral portfolio demonstrates our commitment to listening and responding to our customers’ needs through continuous product innovation,” said Andrew Iott, senior vice president of global product development. “The use of an expandable spacer for the ATP approach may help reduce complications associated with the lateral procedure. With restoration of alignment being of critical importance, these implants were developed as a tool to help surgeons address sagittal imbalance, with the goal of maximizing lordotic correction.”